11.05.2025
Prevention
$222,750.00
36 months
Integrative Multi-Omic and Computational Characterization to Identify Molecular Disease Mechanisms and Therapeutic Targets in Very Early Onset Inflammatory Bowel Disease and Across IBD Populations
Define and validate molecular signatures that drive VEOIBD subgroups and translate these signatures into predictive tools for susceptibility, disease course, and therapeutic response across pediatric and adult CD populations.